Does the CRP rs1205 C allele (CC genotype) associate with higher baseline CRP?

C-reactive protein (CRP) is a primary biomarker of systemic inflammation, and its baseline levels are significantly influenced by genetic variation within the CRP gene. The rs1205 single nucleotide polymorphism (SNP) is one of the most well-characterized genetic determinants of these baseline concentrations.

Evidence from population studies

Extensive genomic research consistently identifies the rs1205 C allele as the "high-CRP" variant across diverse populations.

• Large-scale Meta-analyses: Data from the CHARGE Consortium (n > 80,000) and other meta-analyses involving over 200,000 individuals have confirmed a robust association between rs1205 and circulating CRP. The C allele is significantly linked to higher baseline levels (p < 5e-8).
• Genotype-Specific Effects: Individuals with the CC genotype exhibit the highest baseline concentrations, while each copy of the T allele is associated with a 10% to 15% reduction in CRP. In some cohorts, T allele carriers demonstrate up to 30% lower concentrations per allele compared to the CC genotype.
• Variance Explanation: While statistically significant, this variant explains approximately 1% to 2% of the total variance in baseline CRP levels, which is a substantial portion for a single genetic locus.

Mechanistic explanations

The biological basis for this association lies in the regulation of gene expression rather than a change in the protein's structure.

• 3' UTR Regulation: The rs1205 SNP is located in the 3' untranslated region (3' UTR) of the CRP gene, a site critical for post-transcriptional regulation and mRNA stability.
• MicroRNA Interaction: The T allele (the "low-CRP" variant) appears to create or enhance a binding site for microRNAs, such as miR-409-3p. This interaction leads to increased degradation of the CRP mRNA transcript or reduced translation into protein.
• mRNA Stability: Conversely, the C allele lacks this high-affinity microRNA binding site, resulting in greater mRNA stability and higher constitutive protein synthesis.

Clinical implications

Understanding the rs1205 genotype can help contextualize inflammatory markers in clinical practice.

• Baseline Calibration: For a 30-year-old female, knowing the rs1205 status can help determine whether a slightly elevated CRP is a result of genetic predisposition (CC genotype) rather than an acute inflammatory process.
• Risk Stratification: Because baseline CRP is used to assess cardiovascular risk, genetic variation at this locus suggests that "normal" ranges may vary based on an individual's genetic background.

Bottom line

The association between the rs1205 C allele and higher baseline CRP is well-supported by high-powered population studies. The CC genotype results in higher circulating protein levels due to increased mRNA stability, which should be considered when interpreting hs-CRP results for long-term health assessment.